18-6-1　ⓔ文献

  1. Lane CA, Hardy J, et al: Alzheimer’s disease. Eur J Neurol, 2018; 25: 59–70.

  2. Scheltens P, Blennow K, et al: Alzheimer’s disease. Lancet, 2016; 388: 505–517.

  3. Jack CR Jr, Albert MS, et al: Introduction to the recommendation from the National Institute on Aging and the Alzheimer’s Association working group on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement, 2011; 7: 257–262.

  4. 山田正仁：アルツハイマー病診断におけるSNAPとその背景疾患．Brain and Nerve, 2018; 70: 59–71.

  5. Cummings J, Lee G, et al: Alzheimer’s disease drug development pipleline: 2020. Alzheimers Dement, 2020; 6: e12050.

  6. Arnaoutoglou NA, O’Brien JT, et al: Dementia with Lewy bodies–from scientific knowledge to clinical insights. Nat Rev Neurol, 2019; 15: 103–112.

  7. McKeith I, Boeve B, et al: Recommendations for the diagnosis and management of dementia with Lewy bodies. Fourth report of the DLB consortium. Neurology, 2017; 89: 88–100.

  8. Yamada M, Komatsu J, et al: Diagnostic criteria for dementia with Lewy bodies: updates and future directions. J Mov Disord, 2020; 13: 1–10.

  9. Bang J, Spina S, et al: Frontotemporal dementia. Lancet, 2015; 386: 1672–1682.

  10. Josephs KA, Hodges JR, et al: Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol, 2011; 122: 137–153.

  11. Rascovsky K, Hodges JR, et al: Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain, 2011; 134: 2456–2477.